Latest posts
-
Puravankara Shares In Focus As Group Expands Into Delhi-NCR Market With ₹5,200 Cr GDV Site
Delhi-NCR has long been the market every serious pan-India developer eventually wants a piece of, precisely because it is large, liquid and unforgiving in equal measure. Southern and Western developers in particular have historically stayed cautious about the region, wary of its longer approval cycles and more fragmented land titles. When one of them finally…
-
Symbiotec Pharmalab Q1 FY27: Net Profit Falls 53% YoY to ₹14.1 Crore Despite 7.4% Revenue Growth
It is an R&D driven company which deals with research, development and manufacture of active pharmaceutical ingredients, nutritional ingredients, and other specialty products. The shares of Symbiotec Pharmalab are currently trading at Rs. 1,156.40, Up by 0.13%.The company has a market capitalization of Rs. 7,428.01 crore. The stock’s 52 week high is Rs. 1,193.70 and its…
-
Sensex rises 110 points, Nifty above 23,450 as oil prices, bond yields cool down. Time for a sectoral pivot?
Indian equities traded higher as softer crude prices and easing bond yields improved sentiment. Sensex and Nifty extended gains, while broader markets also advanced. Analysts highlighted a possible sectoral shift towards fairly valued largecaps and improving technical momentum.
-
India’s Biggest IPOs: 5 Issues That Raised Up to ₹27,859 Cr
India’s IPO market has witnessed several large public issues across sectors, reflecting the growing role of equity markets in helping companies and existing shareholders raise substantial capital. While the size of an IPO often attracts significant investor attention, the listing performance of these large issues has varied, influenced by market conditions, valuations and investor sentiment.…
-
Embassy Developments Sells Luxury Juhu Tower To Dinesh Thakkar For ₹711 Cr
The Mumbai arm of one of India’s biggest listed real estate developers just closed a transaction that people in the industry are already flagging as unusual. It isn’t the buyer’s identity alone that’s turning heads though he’s a familiar name in Indian finance, it’s the shape of the deal itself. Rather than selling apartments floor…
-
This stock just beat AI star HFCL’s 230% rally to top Nifty 500 gainers in 2026. Can outperformance last?
Welspun Corp has emerged as the top-performing Nifty 500 stock in 2026 after a 236% rally, overtaking AI infrastructure play HFCL. The sharp gains have been driven by strong investor interest in the company’s oil, gas and water transmission business. The key question now is whether the rally can sustain.
-
Syngene International among 4 stocks that closed crossing above VWAP
Four Nifty 500 stocks closed over 1.5% above their VWAPs on September 21, signaling stronger-than-average trading prices.
-
Moneyview pays Rs 160 crore incentive to CEO ahead of IPO; FY26 profit takes 30% hit
IPO-bound Moneyview paid CEO Puneet Agarwal a one-time Rs 160 crore performance incentive in FY26, reducing reported net profit by about Rs 120 crore after tax. The company said the payment was non-recurring and has no plans for similar incentives. Moneyview’s Rs 1,092-crore IPO opens September 24 at Rs 32-34.
-
Cohance Lifesciences among 5 stocks showing RSI trending up
Five Nifty500 stocks were highlighted in the RSI Trending Up scan on September 21, based on data from StockEdge. Mankind Pharma, Cohance Lifesciences, Kaynes Technology India, Fertilisers And Chemicals Travancore and Jaiprakash Power Ventures recorded rising RSI values.
-
J&K Bank In Focus After Signing Escrow Agreement To Sell PNB MetLife Stake For ₹120 Cr
Banks holding stakes in insurance joint ventures is a legacy of an era when lenders were encouraged to seed the sector alongside foreign and public partners. Many of those holdings have since become passive, non-strategic investments rather than businesses the bank actively runs. Selling them down, in tranches or in full, has become a fairly…